
Evaluation of the Humoral Immune Response Following Two Doses of a Coronavirus Disease 2019 Vector-Based Vaccine During the Initial Rollout in Bangladesh
<a href="https://news.google.com/rss/articles/CBMinAJBVV95cUxNVWlEOGZnN2tXc1owRUZHM3FhSmhXSDB5bkpTdTNsaGFlY1NnLWJuZ0JpYVVrWklqbWpoc2VlQVh0Nm83ZXRZLThjdjAyS0JOQlBXbHhzX3I2RjRNNE1ydUpCRkFWZzZ3bGpwTllrb2x6NFA1MWhXcTVod1RacHJEWnE5eWhwVDhIVTRLeUlHSVB6Y3FKOFdPUld1dlBRaHRoNkRfX1NFczRiSFdYbmNBZ05fRjJ3S0NfRkN4bWtiQjVHTnpDb1NRTzE2QWo0d0VVNmFmaTYtTEtvTE4tRkFGWFFSNWQ0Zk5MeWk1WExEQk43a1VhTm15T1pJX0ZORTVOV3htQ2NKRE5YUThCSUZPZEV0dWJoZXNsbV9KQw?oc=5" target="_blank">Evaluation of the Humoral Immune Response Following Two Doses of a Coronavirus Disease 2019 Vector-Based Vaccine During the Initial Rollout in Bangladesh</a>&nbsp;&nbsp;<font color="#6f6f6f">Cureus</font>
